Using Chromatin Accessibility to Delineate Therapeutic Subtypes in Pancreatic Cancer Patient-Derived Cell Lines
Open Access
- 4 August 2020
- journal article
- research article
- Published by Elsevier BV in STAR Protocols
- Vol. 1 (2), 100079
- https://doi.org/10.1016/j.xpro.2020.100079
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (631701, 535903, 427601, 1162860, 1162556)
- American Association for Cancer Research
- NIH (CA62924, 5R01CA150190-07, P50 CA102701, U01 CA224145)
- Cancer Australia (1143699)
- Cancer Research UK (C29717/A17263, C29717/A18484, C596/A18076, C596/A20921, A23526, A14276, A25233, A29996)
- Wellcome Trust (103721/Z/14/Z)
- Pancreatic Cancer UK (FLF2015_04)
- Scottish Genome Partnership (1175759, 2158447)
- Pancreatic Cancer Research Fund
- MRC
- EPSRC
- Howat Foundation (RBAP10AHJB)
- Associazione Italiana Ricerca Cancro (12182)
- FP7 European Community (602783)
- Italian Ministry of Health (CUP_J33G13000210001)
- Ontario Institute for Cancer Research
This publication has 7 references indexed in Scilit:
- HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerCell Reports, 2020
- ATACseqQC: a Bioconductor package for post-alignment quality assessment of ATAC-seq dataBMC Genomics, 2018
- ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualizationBioinformatics, 2015
- ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐WideCurrent Protocols in Molecular Biology, 2015
- STRING v10: protein–protein interaction networks, integrated over the tree of lifeNucleic Acids Research, 2014
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancerNature, 2012
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010